Conducting Supplier Audits: Ensure Validation Compliance
|
|
- Clare Doris Price
- 6 years ago
- Views:
Transcription
1 Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1
2 Outline Why audit your supplier. Who will audit your supplier. When will you audit your supplier. What will you audit. How will you conduct the audit; Pre-audit questionnaire Areas to be audit and using check lists Close out meeting The advantages and disadvantages of using numerical audit scores. Issuing observation reports and recommendations to your management and to your potential supplier. All rights reserved. Do not copy without permission. 2
3 Why Audit Your Supplier? It is a regulatory requirement To assure yourself that your supplier can provide the required services by virtue of its expertise, technical knowledge, operating capability, financial stability, and sufficient manpower. To ensure that they apply the principles of GXP to your standards since they will become an extension of your operation. All rights reserved. Do not copy without permission. 3
4 Why Audit Your Supplier? To ensure that your supplier remains in compliance. Ensure that your supplier is living-up to commitments made (e.g. to fix things). To investigate issues that may arise during the relationship. All rights reserved. Do not copy without permission. 4
5 Three Types Of Audits Pre engagement audit, or audit to qualify supplier Post engagement audit, or audit to ensure supplier remains viable and in compliance with your requirements. Tactical Audits to address specific concerns or issues. The first two audits are conducted similarly. However, the objectives will differ. The third type focuses on the issue or concern and actions taken to alleviate or correct it. All rights reserved. Do not copy without permission. 5
6 ICH Requirements Q7: Manufacturers should have a system in place to evaluate suppliers, should audit their supplier and they should be approved by the quality unit. Proceeds to detail how an audit maybe conducted. Q9: Quality Risk Management as Part of Materials Management includes assessment and evaluation of suppliers and contract manufacturers to provide a comprehensive evaluation of suppliers and contract manufacturers (e.g., auditing, supplier quality agreements). All rights reserved. Do not copy without permission. 6
7 Example 483 Reports of analysis from component suppliers are accepted in lieu of testing each component for conformity with all appropriate written specifications, without establishing the reliability of the supplier's analyses through appropriate validation of the supplier's test results at appropriate intervals. Procedure Vendor Qualification System, QSOP 020, version October 25, 2000, states "Vendor qualification is established thorough audits, testing and certificates of analysis," however, several suppliers of critical raw materials and components have never been audited. For example : contract testing laboratory for USP raw materials used in production. contract laboratory that conducted validation of endotoxin testing for drug substance and drug product. raw material supplier. supplier of intermediate used in manufacture of drug substance filter supplier for the drug substance purification. All rights reserved. Do not copy without permission. 7
8 FDA 483 Examples Purity, strength and quality of some critical components in the manufacturing are not tested to validate the supplier s test results. No SOP for supplier audits. No audits performed for water, steam or gas suppliers. All rights reserved. Do not copy without permission. 8
9 When to Audit During the supplier qualification process. During the contract negotiation process. Prior to awarding the project. Regularly during the contract period. When an issue arises during contract period. All rights reserved. Do not copy without permission. 9
10 Who Audits Your quality organization is responsible for final approval. They should either audit directly or delegate the audit to third party. Using third party is advantageous in that it eliminates any direct arguments, confrontation, or semblance of favoritism and provide appropriate and current expertise. Auditor must have expertise in: The regulatory and Quality issues associated with project The technical issue relevant to the project Experience in conducting the required type of audit. All rights reserved. Do not copy without permission. 10
11 How to Audit Audits should be documented. Audits should be transparent. Auditor must prepare before hand. Should be conducted using a check list or plan document. Use score or pass fail in grading check list. Audit the facility from which the services will be provided. Observe operation and conduct interviews. Review documentation. Talk to the management. All rights reserved. Do not copy without permission. 11
12 How to Audit Pre-audit questionnaire Info from previous audits if possible Define areas to be audit and use check lists Initial and close out meeting The advantages and disadvantages of using numerical audit scores. All rights reserved. Do not copy without permission. 12
13 How to Audit Some useful techniques: Follow problems as you identify them. Look at the organization of all paper work. Check spelling and grammar, they can be an indication of sloppy record keeping. Keep an eye open on manual transcribing. Transparent audit by letting them know ahead what your plan is, what you find as you find it, do not use gotcha techniques, etc. All rights reserved. Do not copy without permission. 13
14 Conducting The Audit Arrive at your supplier facility and announce yourself and sign in. Pay attention to the reception area. Expect to be escorted to a meeting room and introduced to the management of the organization. Look for cooperative attitude. Conduct initial meeting: What are your objectives. What you will be focusing on. How long do you expect the audit to last. Define who from the supplier s end will accompany you through the audit. All rights reserved. Do not copy without permission. 14
15 Conducting The Audit (Cont.) During initial meeting, request and review some basic documents that may relate to your objective and confirmation of GMP compliance: Facility Layout Diagram and people, and material, Flow Diagrams. Organizational Chart for the Facility Management Team. Position description of responsible personnel. Process flow diagram (PFD) for the product of interest. Confirm the existence of major regulatory documents (NDA, ANDA, 510K, Etc.) The latest process abnormality reports, ensure that proper investigation and appropriate conclusions were reached. All rights reserved. Do not copy without permission. 15
16 Conducting The Audit (Cont.) Begin by going through the quality systems. Review quality policy and manual document(s) Review some of the basic procedures (OOS, Deviation, Change Control, CAPA, etc.) Do they have a comprehensive list of SOPs Calibration, maintenance, and environmental monitoring programs. Look at the standards (Analytical, design, etc.) Training and documentation of such. All rights reserved. Do not copy without permission. 16
17 Conducting The Audit (Cont.) Next follow the operation of interest. Start at the Raw Material receiving, storage and warehousing Follow the process flow Pay attention to how the operation is laid-out, clutter, operator stations adequacy, general house keeping, etc. Batch sheet and batch records, Batch Sheets properly executed Review the various procedures and how well they are followed Gowning and degowning Cleanliness and general maintenance of the facility Labeling of processing equipment and transfer lines Do operators appear to know what they are doing, ask questions Has the process and facility been validated and what is the quality of the validation documents All rights reserved. Do not copy without permission. 17
18 Conducting The Audit (Cont.) Packaging and Labeling Appropriate Procedures. Label Controls. Label count reconciliation. Validation of automated systems Confirmation of use of proper labels on packaged product. All rights reserved. Do not copy without permission. 18
19 Conducting The Audit (Cont.) Facility and Utility Systems Are the critical utilities well documented? Have the critical utilities been validated? Facility cleanliness, maintenance, and orderly progression of the operation. Is there too much clutter? Do they have an environmental monitoring program? Is it too hot? Too cold? Too Humid? Too Noisy? Too tight? Etc. All rights reserved. Do not copy without permission. 19
20 Conducting The Audit (Cont.) Warehousing, storage and materials handling facilities Segregation and well labeled areas. Record keeping Validation of Materials Resource Planning (MRP) system and all other computerized systems Cleanliness and organization Rodent and pest control program Procedures for destruction and disposal of rejects and waste All rights reserved. Do not copy without permission. 20
21 Outline supplier audit (Cont.) Laboratories Validation of instruments and controlled temperature chambers Validated analytical procedures Training and training documentation Labeling of samples, reagents, etc. as to content, expiration dates, date of receipt Cleanliness and organization Note book or record keeping and its adequacy and reviews Procedures for destruction and disposal of rejects and waste All rights reserved. Do not copy without permission. 21
22 Outline supplier audit (Cont.) Other Issues: Financials Safety Environmental stewardship Stand Alone Computerized Systems All rights reserved. Do not copy without permission. 22
23 Auditing Validation Practice Qualification and process validation are critical requirements. Audit your supplier practice based on the new FDA guidance issued in January Ensure that vendor uses the appropriate systems which follow the guidance recommendations All rights reserved. Do not copy without permission. 23
24 Process Validation: General Principles and Practices Guidance to industry issued by the FDA in January 24, Outlines the life cycle approach to validation. Inline with the principles advanced in ICH Q8, ICH Q9, ICH Q10 and in ASTM E2500. Defines PROCESS VALIDATION as the collection and evaluation of data, from the process design stage throughout commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality products. All rights reserved. Do not copy without permission. 24
25 FDA Guidance: Process Validation: General Principles and Practices Replaces the guidance issued in 1987 Quality of the product cannot be assured by simply inspecting or testing in-process and finished products. It must be built into the product-process a-priori. Focusing exclusively on the qualification effort without understanding the process and ensuring the process is maintained in a state of control may not lead to adequate assurance of quality. All rights reserved. Do not copy without permission. 25
26 FDA Guidance To Industry January 2011 Three Stages of Process Validation Process Design Stage (process is defined based on development and scale-up) Process Qualification Stage (Design is confirmed as being capable of reproducible production) Continued Verification and improvement (Continuously gaining assurance the process remains in a state of control) All rights reserved. Do not copy without permission. 26
27 The Life Cycle Approach to Process Validation Planning & Design (ICH Q8) PAT Continuous Verification & Improvement ICH Q9, CAPA, PAT & Change Control ICH Q9 Implementation & Qualification ICH Q10 The Quality System All rights reserved. Do not copy without permission. 27
28 Stage 1: Process Design Understanding the science Understanding the risk Building Quality into the process Establishing Control Strategy All rights reserved. Do not copy without permission. 28
29 Stage 2: Implementation and Process Qualification Implement the process and Facility Qualification of utilities and equipment Performance qualification and PQ protocol Protocol execution and report All rights reserved. Do not copy without permission. 29
30 Stage 3: Continued Process Verification Monitoring appropriate parameters to ensure process in a validated state of control. Use CAPA, PAT and Change control as well as data collected in monitoring to continually improve the process. Proper maintenance of the facility, utilities, and process equipment All rights reserved. Do not copy without permission. 30
31 Auditing Validation Practice Verify documentation of risk analysis during facility, utility systems, and process design Ensure principles of quality by design were applied in addressing the design of risky components of such systems and that design rational is properly documented. Ensure there is a documented control strategy. Ensure qualification of facility, utilities and equipment was performed prior to performing Process Performance Qualification (PPQ). All rights reserved. Do not copy without permission. 31
32 Auditing Validation Practice Ensure PPQ was successfully performed and that there is a certification as to the acceptability of the process. Ensure that the vendor has a process as well as an environmental monitoring program. Ensure the use of proper statistical techniques in analyzing monitoring data. Ensure vendor has the proper quality systems in place which allows for continuous improvement. Ensure vendor has a maintenance and calibration program. All rights reserved. Do not copy without permission. 32
33 Auditing Validation Practice Review procedures associated with validation, eg.: Conducting risk analysis Preparing VMP Preparation of qualification protocols Computer related system validation Protocol execution Responsibilities for the validation CAPA, Deviation reporting & Investigation, Change control Review documentation Sample risk analysis documentation defining validation/qualification requirements Validation/Qualification Master Plan Ensure all systems identified in VMP as requiring qualification were qualified Sample executed protocol against your own standards to determine their acceptability. Sample deviation reports and associated investigation All rights reserved. Do not copy without permission. 33
34 Auditing Validation Practice When reviewing documents: Review for completeness Review for accuracy Review for quality Review for consistency Review for good documentation practices. Ensure that deviations have been addressed and properly resolved prior to closing the protocols. Do not forget the Labs. All rights reserved. Do not copy without permission. 34
35 Example Audit Forms All rights reserved. Do not copy without permission. 35
36 All rights reserved. Do not copy without permission. 36
37 Scoring The Audit Pass All is well, no major quality or compliance issues and better than 75% score Conditional Several minor and correctable quality or compliance issues and score between 60-75% Fail At least one fundamental compliance or quality issue that is not correctable or indicative of organizational problems and a score of less than 60%. All rights reserved. Do not copy without permission. 37
38 Advantages of Numerical Audit Makes the audit more objective and less subjective. Reduces the entire audit to one or two numbers which are used to make the decision. Has well defined questions upfront and thus nothing is forgotten. All rights reserved. Do not copy without permission. 38
39 Disadvantages of Numerical Audits Reduces the entire audit to one or two numbers which are used to make the decision. May result in a major item being overlooked because of all other issues being excellent (use weighing). Could limit the ability to follow issues as they arise since the questions are predefined. All rights reserved. Do not copy without permission. 39
40 Audit Report Format The Audit Final Report will include: Description of the reason for the audit Description of the product / process and its relationship to the audit requisitioner. Description of facility, utility systems and process equipment Identification of the individuals responsible for the execution of the audit and their qualifications Identification of the flow of material / personnel and equipment Identification of the programs, controls, systems and processes to be observed and reviewed Identification of the questionnaire(s) and site tour agenda to be utilized in the execution of the audit Identification of the Supplier Audit Check List and the Results Summary Listing of appropriate observations Listing of recommendations (if requested by audit requisitioner) All rights reserved. Do not copy without permission. 40
41 Audit Report Format The Final Report Table Of Content: Objective Scope General Description Product / Process Specific Description Responsibilities Methodology / Procedure Observations Supplier Rating Recommendations Appendices All rights reserved. Do not copy without permission. 41
42 Summary Auditing your supplier is a regulatory requirement. Auditing your supplier is your way of confirming their capabilities and compliance status. Auditor must be experienced and knowledgeable. Use a formal auditing approach and experienced auditors. Conduct transparent audits. All rights reserved. Do not copy without permission. 42
43 Interactive Exercise Develop a check list to guide auditing of Validation of a Oral Solid Dosage Process. All rights reserved. Do not copy without permission. 43
44 OSD Process Excipient Wetting agent Active Weighing & Dispensing Mixing Granulation Wet Milling Drying To Packaging Coated Tablets Coating Binder Tablet Press Additives Blending Air Milling & Screening Coating Material All rights reserved. Do not copy without permission. 44
45 The Equipment Weighing and dispensing: Weighing scales (floor scales, Scales, utensils) Directional Air Flow weighing booths IBC (Intermediate Bulk Containers) Powder conveying equipment Lifts, forklifts, skids, etc. All rights reserved. Do not copy without permission. 45
46 The Equipment Mixing Mixing tanks Mixers IBC tumblers Dispensing systems All rights reserved. Do not copy without permission. 46
47 The Equipment Granulation: Charge tanks Granulators Feed system Conveying system All rights reserved. Do not copy without permission. 47
48 The Equipment Drying: Charging equipment Bowl Invertors Lifts Conveying system Fluid bed with associated air handling and dust collection Microwave Oven Vacuum All rights reserved. Do not copy without permission. 48
49 The Equipment Blending and Tablet presses: Charging equipment Lifts Conveying system Blenders Tablet press Coating Drum Coating Spray coating Totes and tablet handling equipment All rights reserved. Do not copy without permission. 49
50 The Equipment Laboratory Equipment Gas Chromatographs HPLC equipment Dissolution Bath General case work Laboratory glassware and general support equipment Other Automation Monitoring Building condition controls All rights reserved. Do not copy without permission. 50
MASTER PLANNING FOR VALIDATION
MASTER PLANNING FOR VALIDATION By: Gamal Amer, Ph.D. Principal, Premier Compliance Services, Inc. 1 Process Validation: General Principles and Practices Guidance to industry issued by the FDA in January
More informationThe World Bank. Aide Memoire for use during GMP inspections
The World Bank e for use during GMP inspections The World Bank Procurement of Health Sector Goods Contact persons: 0 1. General information about the manufacturer Name of manufacturer Physical address
More informationDr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur
Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur GMP ( Adopted in 1975 ) In India Good manufacturing practices are the practices required in order to conform to guidelines recommended
More informationRegistered Starting Material Auditing Guide
Registered Starting Material Auditing Guide Annex 1 Aide Mémoire Company : Auditor(s) : Location, Country : Date of Audit: APIC Guide for Auditing Registered Starting Material Manufacturers Remark: Non-compliance
More informationPrequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer
Prequalification of Medicines Programme. WHO PUBLIC INSPECTION REPORT API Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) API Manufacturer Part 1: General information Name of Manufacture Unit number
More informationSupersedes Division Name Revision No. 0 Export Division Page No. 1 of 9
Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This
More informationGMP The Other Side of Chemistry, Manufacturing & Controls (CMC)
Overview of USFDA Drug Regulatory Requirements Pharmaceutical Quality and Facility Inspections (GMP) Session II 19 February 2014 Casablanca, Morocco GMP The Other Side of Chemistry, Manufacturing & Controls
More informationContents. Contents (13) 1 Production (23)
1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing
More informationOverview of Regulatory Requirements for API and Formulations
Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed
More informationGuidelines for Process Validation of Pharmaceutical Dosage Forms
Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical
More informationSubpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.
FDA inspections continue to focus on CGMP violations related to basic GMP controls. A survey of Warning Letters issued in 2013 on CMC (Chemistry / Manufacturing / Controls) violations reveals an emphasis
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General
More informationIndustry Perspective on Manufacturing in Early Development
Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical
More information18.H Questionnaire for preparing GMP-inspections
Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current
More informationPrequalification of Medicines Programme
Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General
More informationDocumenta tion and Records
Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.
More informationEffective Management and Operations of GXP Laboratories
Effective Management and Operations of GXP Laboratories Course Objective: Upon completion of this course, attendees involved in establishing and assuring that Good Laboratory / Good Manufacturing Practice
More informationPrequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets
Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: information about the inspection Name of manufacturer Physical address production departments
More informationInspection. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory
More informationDrug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel
Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active
More informationAuditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s
Tech Tip 0020 With the advent of the cgmp s, the majority of companies are increasing the frequency of their outsourced analytical testing. But the GMPs are just that, Good Manufacturing Practices, and
More informationEFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT
EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago
More informationCOMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS
COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance
More informationQUALITY SYSTEMS INSPECTIONS TECHNIQUE
QUALITY SYSTEMS INSPECTIONS TECHNIQUE Notice: This draft document represents the Agency' current thinking on the subject of Quality System Inspections. It is provided to the public in order to stimulate
More informationSITE MASTER FILE For MHRA
ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of
More informationPrequalification Team Inspection services WHO INSPECTION REPORT of the FPP manufacturer
Prequalification Team Inspection services WHO INSPECTION REPORT of the FPP manufacturer Part 1 Manufacturers details Company information Name of manufacturer Corporate address of manufacturer Contact person
More informationLibrary Guide: Active Pharmaceutical
Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the
More informationPharmaceutical Good Manufacturing Practice. Contents are subject to change. For the latest updates visit
Pharmaceutical Good Manufacturing Practice Page 1 of 6 Why Attend A robust quality system that meets the requirements of pharmaceutical regulators is an essential element of every good pharmaceutical manufacturing
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More informationHACCP audit checklist
Requirement HACCP audit checklist Prerequisite Program Management Commitment 1. Senior management ensures that the responsibilities and authorities are defined and communicated within the company Internal
More informationDeveloping an Internal Quality Auditing Program
Developing an Internal Quality Auditing Program SeerPharma Pty Lt Capsig August 2009 1 Critical Success Factors Culture of Compliance Integrate quality systems and risk management principles Well defined
More informationProcess development and basic GMP
Process development and basic GMP Aulton Chapter 45, handouts Specification, stability, inprocess controls and validation Product development Process development Critical Product Qualities issues Critical
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer
Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Calyx Chemicals & Pharmaceuticals Ltd Unit:
More informationQUALITY AGREEMENT. The following Agreement has been concluded between
QUALITY AGREEMENT The following Agreement has been concluded between LLC LABORATORIES The contract laboratory and service provider 1625 Trinity Dr., Unit 11 Mississauga, Ontario Canada L5T 1W9 Hereinafter
More informationWARNING LETTER AUG 3, 2016
Ropack, Inc. 8/3/16 Department of Health and Human Services Public Health Service Food and Drug Administration 10903 New Hampshire Avenue White Oak Building 66 Silver Spring, MD 20993 WARNING LETTER AUG
More informationApplication of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013
Application of PAT for Tablet Analysis Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Agenda PAT@Novartis Organization Business Drivers and Cases NIR Spectroscopy for
More informationEUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU
More informationGood Manufacturing Practices Purpose and Principles of GMP. Tony Gould
Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines
More informationUSP Chapter 823 USP 32 (old) vs. USP 35 (new)
USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has
More informationEffective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs) *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! The globalization of the pharmaceutical
More informationEffective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION The globalization of the pharmaceutical supply chain has led increased use of Contract Manufacturing
More informationPHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM
Course Title Course Code PHARMACEUTICAL VALIDATION AND QUALITY MANAGEMENT SYSTEM QA204 Lecture : 04 Course Credit Practical : 04 Tutorial : 00 Total : 08 Course Objective To explain the students about
More informationGood manufacturing practices
ORIGINAL PAPER 1AR-10 ISBT Science Series (2009) 4, 6 10 Journal compilation 2009 International Society of Blood Transfusion Good manufacturing practices Blackwell Publishing Ltd A. Ahmed Quality Manager,
More informationAnnex 4. Guidance on good manufacturing practices: inspection report. Background
Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)
More informationControl Strategy. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 Control Strategy International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Introduction Structure of this session
More informationNQA-1 Graded Approach, 55-Gallon Drum Summary
1, Organization 2, Quality Assurance program 3, Design 4, Procurement Document 5, Instructions, procedures, and Drawings 100 Basic 200 Structure and Responsibility 201 General 202 Delegation of Work 300
More informationSUPPLIERS QUALIFICATION
SUPPLIERS QUALIFICATION With each passing day, new suppliers and manufacturers of packaging materials, raw materials, laboratories, etc., appear, offering products and services of different quality levels.
More informationGood practices in quality control in pharmaceutical industry - Overview of regulatory guidelines
Review Article Good practices in quality control in pharmaceutical industry - Overview of regulatory guidelines Chagi Venkatesh*, S. B. Puranik ABSTRACT Good practices in quality control (QC) department
More informationAn Introduction to Double Dragon Consulting
An Introduction to Double Dragon Consulting www.doubledragonconsulting.com 1 June 2012 About DDC Our Experience: All dosage forms, aseptic processes, OTC Remediation of 483 observations, warning letters,
More informationWHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Mylan Nashik ( Sinnar in CRM) AND
SOP 408.4 Annex D 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer
More informationValidation of Pharmaceutical Manufacturing Process Focus: APIs.
Validation of Pharmaceutical Manufacturing Process Focus: APIs Validations: Regulatory History (US FDA) Sterilisation 1977 Aseptic processing 1979 Water Systems 1981 Non-sterile Mfg Process 1987 Revised
More informationThe FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics
The FDA Just Arrived... Are You Ready? Presented By Sandra Lueken Sr. Director, Quality AstraZeneca Biologics Objectives Review Quality Systems Audit Approach and cgmp fundamentals Logistical Audit Preparation
More informationPROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION
1 Working document QAS/13.527/Rev.2 August 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer
Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer / Iksan Plant Unit number Production Block Physical address Contact person and email
More informationContent PART I: ANDA Roadmap PART II: Understanding of CPPs & CQAs PART III: Scale-Up and Technology Transfer PART IV: Process Validation & Sampling 2
EMA, FDA- ANDA Readiness -OSD Generics Solution Post Formulation Development Horch Guo, May. 2016, Changzhou, China Hongxing.guo@yahoo.com Content PART I: ANDA Roadmap PART II: Understanding of CPPs &
More informationGMP On Site Series. GMP Essentials
GMP On Site Series GMP Essentials GMP Basics Objectives 1. State the critical definitions of the pharmaceutical industry. 2. Describe the law as it applies to various critical functions. 3. State the history
More informationQuality Manual ISO 9001:2000
Quality Manual ISO 9001:2000 Page 2 of 23 TABLE OF CONTENTS COVER PAGE...1 TABLE OF CONTENTS...2 SIGNATURES...3 QUALITY POLICY...4 INTRODUCTION...5 CORPORATE PROFILE...9 4.O QUALITY MANAGEMENT SYSTEM...10
More informationQuality Assessment & GMP Similarities & Differences
Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences
More informationSESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt
Validation Services SESSION 14 Documentation Requirements and Management for Validation 30 March 2017 Frits Vogt fritsvogt@valserv.nl Content Documentation Requirements and Management for Validation I.
More informationQuality System Regulation (QSR) Training
Quality System Regulation (QSR) Training Or How to Ensure Development, Production and Sale of Safe, Effective, Consistent Product FDLI February 2003 Overview QSR History, Purpose and Scope Changes from
More informationNIRS, PAT, RTR testing EU experience and regulatory perspective
NIRS, PAT, RTR testing EU experience and regulatory perspective Heidelberg, Germany October 2013 European Compliance Academy (ECA) Overview of the presentation General considerations Cases submitted in
More informationWhile the recognition
Designing the Perfect Change Control System Change control systems today are expected to be designed in a way that provides a system to not only document and approve changes, but also to anticipate change
More informationPrequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer
Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Shanghai Shyndec Pharmaceutical (Haimen)
More informationQuality Agreement. by and between. Supplier Name. Address: and. Client Name: Address:
NOTE TO USERS This Quality Agreement template was developed by the Bulk Pharmaceutical Task Force (BPTF), an affiliate organization of the Society of Chemical Manufacturers and Affiliates (SOCMA), as a
More informationPURITAN PRODUCTS QUALITY OVERVIEW. Quality Management System Self-Audit. September 15, 2015
PURITAN PRODUCTS QUALITY OVERVIEW Quality Management System Self-Audit September 15, 2015 Founded in 1987, Puritan Products, Inc. is a cgmp compliant, FDA registered and inspected, and ISO-9001:2008 certified
More informationAnnex 6. Good trade and distribution practices for pharmaceutical starting materials
Annex 6 Good trade and distribution practices for pharmaceutical starting materials Introduction 212 1. Quality management 213 2. Organization and personnel 214 3. Premises 215 4. Procurement, warehousing
More informationRECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS
RECOMMENDATIONS FOR DIETARY INGREDIENT PROCESSORS Facilities that manufacture 117, pack, or hold dietary supplements are subject to the regulations in 21 CFR Part 111, while those that manufacture, pack,
More informationEquipment cleaning and use record
DOCUMENTATION Documentation is an essential part of the quality assurance system and, as such, should be related to all aspects of GMP. Its aim is to define the specifications for all materials and the
More informationGMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)
GMP Requirements Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP) 2016. ALL RIGHTS RESERVED. Outline GMP Procedures and standards
More informationSession 10: The UNFPA Prequalification Site Inspection
Session 10: The UNFPA Prequalification Site Inspection Group Brainstorm: Site Inspection In your experience, in what areas have you disagreed with the inspectors? Objectives Provide overview of what inspectors
More informationCONSIDERATIONS OF CONTINUOUS MANUFACTURING PROCESSES
LCDR Patric Klotzbuecher U.S. FDA/Office of Regulatory Affairs/New York District 3 rd FDA/PQRI Conference on Advancing Product Quality March 22 24, 2017 CGMP AND REGULATORY CONSIDERATIONS OF CONTINUOUS
More informationChristine Oechslein. GMP Focus. Managing Process Validation. A Drugmaker s Guide. PDF Download. Excerpt from the GMP MANUAL
Christine Oechslein GMP Focus Managing Process Validation A Drugmaker s Guide PDF Download Excerpt from the GMP MANUAL Bibliographic Data of the Deutsche Nationalbibliothek: http://dnb.ddb.de ISBN: 978-3-95807-056-1
More informationLatino America Consultores Innovation & Technology to make your Business Compliant
Latino America Consultores Innovation & Technology to make your Business Compliant Annex 15 & EMA Process Validation Guide Line 1 Changes in Requirements The Pharmaceutical Industry has adapted its business
More informationGMP Challenges to Global Pharma Companies
GMP Challenges to Global Pharma Companies Muralidhara B. Gavini, Ph.D. Senior Assistant Country Director India Mumbai Office, Office of International Programs Office of the Commissioner Food & Drug Administration
More informationSUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION
Pharmapathway.com SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES (GMP): VALIDATION Page 1 of 43 1. INTRODUCTION Validation is an essential and integral part of Good Manufacturing Practice (GMP).
More informationT H E P R O P O S A L F O R T H E Y E A R
Training T H E P R O P O S A L F O R T H E Y E A R 2 0 1 9 Our GMP courses combine a convenient format with an effective, interactive learning experience. To maximize and customize your professional development.
More informationPROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION
1 Working document QAS/13.527/Rev.1 April 2014 RESTRICTED 2 3 4 5 6 7 8 9 10 PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS
More informationManufacturing Technology Committee Risk Management Working Group Risk Management Case Studies. Case No. RMWG-07. Space
Manufacturing Technology Committee Risk Management Working Group Risk Management Case Studies Case Study Title: Defining Process Design Space Case No. RMWG-07 GMP System Impacted: Introduction / Background
More informationA Compilation of WHO GMP Audit Points
A Compilation of WHO GMP Audit Points Collected from WHOPIR of 28 companies Part VIII of VIII Current article Part VIII Support QMS Prepared and Submitted By: Edited by : A. Jwalakanth B.Pharm, MBA (Aus)
More informationQbD Concepts Applied to Qualification and Transfer of Analytical Methods
QbD Concepts Applied to Qualification and Transfer of Analytical Methods CMC Strategy Forum Latin America - 2014 Patrick Swann Senior Director Technical Development QbD = Quality by Design QbD - A systematic
More informationGOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS. REVISION
July 2013 RESTRICTED 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 GOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS.
More informationScientific and Regulatory Considerations for Continuous Manufacturing Implementation for Drug Product
Scientific and Regulatory Considerations for Continuous Manufacturing Implementation for Drug Product Arwa El Hagrasy, Ph.D. Quality Assessment Lead (Acting) Office of Process and Facilities OPQ/FDA PQRI
More informationAudit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017
Audit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017 FDA 483 Observations 2 FDA 483 Observations 3 FDA 483 Observations 4 Auditing Validation How to cover
More informationIncremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.
Incremental GMPs Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, 2017 1/55 Sound Science Good Development Practice Traceability R&D Tox I II III IV What You Need Here Can t be generated here
More informationSUPPLIER QUALITY SYSTEM SURVEY
SUPPLIER QUALITY SYSTEM SURVEY DATE (M/d/yy): 55 Dragon Court Woburn, MA 01801 Tel: (781) 933-7300 Fax: (781) 935-4529 GENERAL INFORMATION Supplier Name: Physical Address: City: State: Zip: Sr. Company
More informationLessons from Pharmaceutical Laboratory related FDA Warning Letters
Lessons from Pharmaceutical Laboratory related FDA Warning Letters The Agilent Critical Compliance Seminar 2016 Ludwig Huber Ludwig_huber@labcompliance.com Overview FDA Inspections and reports GMP compliance
More informationPERFORMANCE QUALIFICATION PROTOCOL HVAC SYSTEM
Page 1 of 24 PERFORMANCE QUALIFICATION PROTOCOL FOR HVAC SYSTEM Signing of this Performance Qualification Protocol indicates agreement with the Validation Master Plan approach of the equipment. Further
More informationSECTION L QUALITY ASSURANCE. 1) designating and managing quality control functions, including:
NT-L1.000 QUALITY ASSURANCE PROGRAM All NADOs shall have a QA Program. Current (2 nd Edition) NT-L1.100 BASIC ELEMENTS SECTION L QUALITY ASSURANCE The QA program shall include, at a minimum: 1) designating
More informationEquipment Design Consideration for Cleaning & Cleaning Validation
Equipment Design Consideration for Cleaning & Cleaning Validation Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Cleaning and Cleaning
More informationPharmaceutical control strategy what does it mean and how do we apply? Martin Warman, Martin Warman Consultancy Ltd
Pharmaceutical control strategy what does it mean and how do we apply? Martin Warman, Martin Warman Consultancy Ltd How can the words control strategy cause such debate? Means totally different things
More informationLABORATORY COMPLIANCE
1 LABORATORY COMPLIANCE Jeanne Moldenhauer Vectech Pharmaceutical Consultants, Inc. Farmington Hills, MI INTRODUCTION Implementation of the Systems-Based Inspection Guideline for drug manufacturers in
More informationSan Jose, California, USA
Glisland, Inc. San Jose, California, USA http://www.glisland.com Welcome to the Drug GMP World Current Good Manufacturing Practice cgmp ICH Q10 Pharmaceutical Quality System PQS GMP QSR Quality System
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, 6 February 2014 SANCO/TSE/ The received contributions together with the identity of
More informationValidation Boot Camp. Validation Fundamentals: Conducting a Successful Validation Project
Validation Boot Camp Validation Fundamentals: Conducting a Successful Validation Project Learning Objectives Upon completion of this workshop, participants will be able to: Understand FDA and GMP terms
More informationGeneral European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT
General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (16) 86 R2 MANAGEMENT OF ENVIRONMENTAL CONDITIONS Full document title and reference Document type Management of Environmental
More informationYour partner in the pharmaceutical industry
English Micronisation- and milling service Micronised by GfM Your API Particle size (µm) Your partner in the pharmaceutical industry The... always that little bit finer. We are a family business in the
More informationEnabling Improvement through the Product Lifecycle: Change Management within a PQS
Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,
More informationGMP Inspection Deficiencies Review of Deficiencies Observed in 2013.
GMP Inspection Deficiencies 2013 Review of Deficiencies Observed in 2013. Executive Summary The most frequently encountered defect categories raised over the previous five years have remained relatively
More informationLifecycle Product Quality Risk Management
Lifecycle Product Quality Risk Management Richard L. Friedman, M.S. Associate Director Office of Manufacturing and Product Quality Office of Compliance IFPAC Annual Meeting (Arlington, VA) January, 21-24,
More information